Table 2.
Placebo | E2 | P valuea | |
---|---|---|---|
n | 89 | 91 | |
E1 (pg/ml) | |||
Baseline | 39.8 (13.3) | 47.0 (31.2) | 0.05 |
Follow-up | 48.1 (42.0) | 310.3 (167.2) | <0.0001 |
E2 (pg/ml) | |||
Baseline | 19.1 (5.3) | 21.4 (19.7) | 0.27 |
Follow-up | 14.7 (6.3) | 68.2 (16.2) | <0.0001 |
Free E2 (pg/ml) | |||
Baseline | 0.5 (0.2) | 0.6 (0.5) | 0.25 |
Follow-up | 0.6 (0.2) | 1.6 (0.6) | <0.0001 |
SHBG (nmol/liter) | |||
Baseline | 35.2 (14.5) | 35.2 (18.5) | 0.90 |
Follow-up | 36.5 (18.2) | 58.2 (23.6) | <0.0001 |
Data are expressed as mean (sd).
P values were from t test for independent samples.